PATENT ROUNDUP FROM EUROPE (AND BEYOND)


The IPKat notes the following patent cases from outside his usual stomping ground:

* Mobile Burn notes that mobile phone manufacturers Nokia and Vitelcom have settled a patent dispute pending in the German and Spanish courts with a royalty bearing patent licence agreement covering certain Nokia patents relating to the GSM/GPRS Mobile Communication Standard and the grant of a cross licence to Nokia under Vitelcom patents in the same field. The IPKat notes that the press release by Nokia on the issue is very terse – if they came out on top, what’s the big secret?

* According to the Boston Business Journal, Genzyme is suing Transkaryotic in Israel, claiming that Transkaryotic has infringed its patent for glucocerebrosidase compound, which is used in the treatment of Gaucher disease. Both companies are based in Massachusettes so the IPKat would like to know, why Israel?

* The Financial Times reports that Sanofi-Aventis’ patent for the blood thinning drug Plavix is being challenged in the Scottish courts for lack of novelty by Aircoat. The IPKat welcomes the change for the Scottish courts to flex their IP muscles.

More Scottish patents here, here and here
PATENT ROUNDUP FROM EUROPE (AND BEYOND) PATENT ROUNDUP FROM EUROPE (AND BEYOND) Reviewed by Anonymous on Wednesday, January 26, 2005 Rating: 5

2 comments:

  1. i really like your new property spanish blog site , my site www.discount-spanish-property.co.uk has lots of new property spanish related resources

    ReplyDelete
  2. Nice Site. We have Free Houses on my site. Please take a look real estate title company

    ReplyDelete

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html

Powered by Blogger.